John Orloff
2018
In 2018, John Orloff earned a total compensation of $4.9M as Executive Vice President, Head of Research & Development at Alexion Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $973,350 |
|---|---|
| Salary | $695,250 |
| Stock Awards | $3,096,323 |
| Other | $98,679 |
| Total | $4,863,602 |
Orloff received $3.1M in stock awards, accounting for 64% of the total pay in 2018.
Orloff also received $973.4K in non-equity incentive plan, $695.3K in salary and $98.7K in other compensation.
Rankings
In 2018, John Orloff's compensation ranked 2,092nd out of 14,244 executives tracked by ExecPay. In other words, Orloff earned more than 85.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,092 out of 14,244 | 85th |
Division Manufacturing | 758 out of 5,759 | 87th |
Major group Chemicals And Allied Products | 252 out of 2,122 | 88th |
Industry group Drugs | 201 out of 1,811 | 89th |
Industry Pharmaceutical Preparations | 155 out of 1,385 | 89th |
Source: SEC filing on March 26, 2019.
Orloff's colleagues
We found five more compensation records of executives who worked with John Orloff at Alexion Pharmaceuticals in 2018.
2018
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2018
Julie O'Neill
Alexion Pharmaceuticals
Former Executive Vice President of Global Operations
2018
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2018
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Patient and Employee Experience Officer
2018
Brian Goff
Alexion Pharmaceuticals